CardioDx

About:

CardioDx is a cardiovascular genomic diagnostics company providing clinicians with information to enhance patient care.

Twitter/X: cardiodx

Top Investors: TPG, Temasek Holdings, Intel Capital, Kleiner Perkins, Alberta Investment Management

Description:

CardioDx is a cardiovascular genomic diagnostics company located in Palo Alto, CA. CardioDx develops clinically validated genomic tests to aid in assessing and tailoring care of individuals with cardiovascular disease, including coronary artery disease (CAD), cardiac arrhythmias, and heart failures.

Total Funding Amount:

$337M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Redwood City, California, United States

Founded Date:

2004-01-01

Contact Email:

info(AT)cardiodx.com

Founders:

David Levison